1. Home
  2. ZSTK vs MBAI Comparison

ZSTK vs MBAI Comparison

Compare ZSTK & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZSTK

ZeroStack Corp. Common Stock

N/A

Current Price

$4.01

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.74

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ZSTK
MBAI
Founded
2019
2004
Country
Canada
Israel
Employees
21
85
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZSTK
MBAI
Price
$4.01
$1.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.4K
148.9K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$1.29
52 Week High
$11.00
$3.92

Technical Indicators

Market Signals
Indicator
ZSTK
MBAI
Relative Strength Index (RSI) 39.52 53.41
Support Level $3.72 $1.35
Resistance Level $5.86 $1.91
Average True Range (ATR) 0.75 0.18
MACD -0.03 0.03
Stochastic Oscillator 29.44 54.56

Price Performance

Historical Comparison
ZSTK
MBAI

About ZSTK ZeroStack Corp. Common Stock

ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: